J&J Unit's Topamax Warnings Were Inadequate, Jury Told

Law360, Philadelphia (March 4, 2014, 5:38 PM EST) -- A Johnson & Johnson unit's failure to warn doctors about the risks associated with the epilepsy medication Topamax resulted in a Wisconsin couple's child being born with birth defects, an attorney for the family told a jury during closing arguments in a Pennsylvania court trial on Tuesday.

David Matthews, an attorney with Matthews & Associates representing the family of 5-year-old Payton Anderson, told a jury in the Philadelphia County Court of Common Pleas that Janssen Pharmaceuticals Inc. had failed to update Topamax's label to reflect data...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.